Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook
Related Markets
Asia Pacific veterinary active pharmaceutical ingredients manufacturing market highlights
- The Asia Pacific veterinary active pharmaceutical ingredients manufacturing market generated a revenue of USD 2,505.4 million in 2024.
- The market is expected to grow at a CAGR of 8.2% from 2025 to 2033.
- In terms of segment, in house was the largest revenue generating service type in 2024.
- Contract Outsourcing is the most lucrative service type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2033.
Asia Pacific data book summary
| Market revenue in 2024 | USD 2,505.4 million |
| Market revenue in 2033 | USD 5,074.2 million |
| Growth rate | 8.2% (CAGR from 2025 to 2033) |
| Largest segment | In house |
| Fastest growing segment | Contract Outsourcing |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | In House, Contract Outsourcing |
| Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 26.8% of the global veterinary active pharmaceutical ingredients manufacturing market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,074.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Scope
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Excel Industries | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | http://www.excelind.co.in |
| Suanfarma Biotech | View profile | 251-500 | Alcobendas, Madrid, Spain, Europe | http://www.suanfarma.com |
| Vetpharma | View profile | 11-50 | Barcelona, Catalonia, Spain, Europe | https://vetpharma.com |
| Siflon Drugs & Pharmaceuticals | View profile | 11-50 | Hyderabad, Andhra Pradesh, India, Asia | https://siflonpharma.com |
| The Chem-Pro Group | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | https://www.chemprogroup.com |
| Ofichem Group | View profile | 51-100 | Ter Apel, Groningen, The Netherlands, Europe | https://ofichem.com |
| SeQuent Scientific | View profile | 1001-5000 | Bangalore, Karnataka, India, Asia | http://sequent.in |
| Menadiona | View profile | 51-100 | Barcelona, Catalonia, Spain, Europe | https://www.menadiona.com/ |
| Zoetis Inc Class A | View profile | 14100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | https://www.zoetis.com |
Asia Pacific veterinary active pharmaceutical ingredients manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.
In house was the largest segment with a revenue share of 63.13% in 2024. Horizon Databook has segmented the Asia Pacific veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2021 to 2033.
The veterinary API manufacturing market in Asia Pacific is expected to grow at a lucrative rate over the forecast period. The market is driven by high investments in R&D by global players and consistent efforts to commercialize veterinary pharmaceuticals at relatively low prices.
In addition, the need to curb the high prevalence of zoonotic disease and manage disease outbreaks, such as swine influenza and Ebola, is expected to propel market growth over the forthcoming decade.Growth in the region can also be attributed to a significantly high cattle population.
According to the report published by the U.S. Department of Agriculture (USDA), in 2023, China and India constitute over 43% of the global cattle population. Furthermore, rising disposable income increases the chances of adopting companion animals, creating future growth opportunities.
Reasons to subscribe to Asia Pacific veterinary active pharmaceutical ingredients manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific veterinary active pharmaceutical ingredients manufacturing market databook
-
Our clientele includes a mix of veterinary active pharmaceutical ingredients manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific veterinary active pharmaceutical ingredients manufacturing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific veterinary active pharmaceutical ingredients manufacturing market size, by country, 2021-2033 (US$M)
Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
